Micro Emerging Active

Risultati del trial di richiamo vaccino RSV

Punteggio
0,2
Velocità
▲ 0,0
Articoli
1
Fonti
1

Riepilogo

An article belongs to this narrative if it discusses the Phase I clinical trial results of Clover Biopharmaceuticals' RSV PreF vaccine candidate.

Articoli Correlati

Clover Biopharmaceuticals Reports Positive U.S. Phase I Data On RSV Re-Vaccination In Older Adults

Nasdaq · Mar 25, 2026
Mixed

Fonti

Clover Biopharmaceuticals Reports Positive U.S. Phase I Data On RSV … Nasdaq

Cronologia

Ultimo aggiornamento Mar 25, 2026